ADRA2C Antikörper (C-Term)
Kurzübersicht für ADRA2C Antikörper (C-Term) (ABIN7184590)
Target
Alle ADRA2C Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Verwendungszweck
- ADRA2C Antibody
-
Kreuzreaktivität
- Maus, Ratte
-
Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthesized peptide derived from the C-terminal region of Human AR alpha2C.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- ADRA2C (Adrenergic, alpha-2C-, Receptor (ADRA2C))
-
Andere Bezeichnung
- ADRA2C
-
Hintergrund
- ADRA2C antibody, ADRA2L2 antibody, ADRA2RL2Alpha-2C adrenergic receptor antibody, Alpha-2 adrenergic receptor subtype C4 antibody, Alpha-2C adrenoreceptor antibody, Alpha-2C adrenoceptor antibody, Alpha-2CAR antibody
-
UniProt
- P18825
-
Pathways
- EGFR Signaling Pathway, cAMP Metabolic Process
Target
-